FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine
- FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
- FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
- FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
- FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
- FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food
- FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
- FDA Issues Emergency Use Authorization for Drug for Short-Term Prevention of New World Screwworm in Horses
- FDA Proposes Rule to Modernize Drug Manufacturing Registration
- FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
- FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
- FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
- FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health
- FDA Approves First Single-Dose Generic Treatment for Influenza
- FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose